Phase II Trial of Capecitabine Plus Bevacizumab for Elderly Patients With Metastatic Colorectal Cancer: OGSG 1102

TOSHIFUMI YAMAGUCHI; MOTOKI YOSHIDA; KOICHI TAIRA; SHINYA TOKUNAGA; TAKESHI KATO; MASATO NAKAMURA; NAOTOSHI SUGIMOTO; SOICHI FUMITA; MASAYOSHI YASUI; YASUHIRO MIYAKE; HISATO KAWAKAMI; YUKINORI KUROKAWA; TOSHIO SHIMOKAWA; TAROH SATOH

doi:10.21873/invivo.13950

Research ArticleClinical Studies

Open Access

Phase II Trial of Capecitabine Plus Bevacizumab for Elderly Patients With Metastatic Colorectal Cancer: OGSG 1102

TOSHIFUMI YAMAGUCHI, MOTOKI YOSHIDA, KOICHI TAIRA, SHINYA TOKUNAGA, TAKESHI KATO, MASATO NAKAMURA, NAOTOSHI SUGIMOTO, SOICHI FUMITA, MASAYOSHI YASUI, YASUHIRO MIYAKE, HISATO KAWAKAMI, YUKINORI KUROKAWA, TOSHIO SHIMOKAWA and TAROH SATOH

In Vivo May 2025, 39 (3) 1505-1513; DOI: https://doi.org/10.21873/invivo.13950

TOSHIFUMI YAMAGUCHI

1Cancer Chemotherapy Center, Osaka Medical and Pharmaceutical University, Osaka, Japan;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: toshifumi.yamaguchi{at}ompu.ac.jp

MOTOKI YOSHIDA

1Cancer Chemotherapy Center, Osaka Medical and Pharmaceutical University, Osaka, Japan;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

KOICHI TAIRA

2Department of Medical Oncology, Osaka City General Hospital, Osaka, Japan;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

SHINYA TOKUNAGA

2Department of Medical Oncology, Osaka City General Hospital, Osaka, Japan;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

TAKESHI KATO

3Department of Surgery, Kansai Rosai Hospital, Amagasaki, Japan;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

MASATO NAKAMURA

4Aizawa Comprehensive Cancer Center, Aizawa Hospital, Matsumoto, Japan;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

NAOTOSHI SUGIMOTO

5Department of Medical Oncology, Osaka International Cancer Institute, Osaka, Japan;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

SOICHI FUMITA

6Department of Medical Oncology, Kishiwada City Hospital, Kishiwada, Japan;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

MASAYOSHI YASUI

7Department of Surgery, Kaizuka City Hospital, Kaizuka, Japan;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

YASUHIRO MIYAKE

8Department of Surgery, Nishinomiya Municipal Central Hospital, Nishinomiya, Japan;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

HISATO KAWAKAMI

9Department of Medical Oncology, Kindai University Faculty of Medicine, Higashi-osaka, Japan;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

YUKINORI KUROKAWA

10Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Osaka, Japan;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

TOSHIO SHIMOKAWA

11Department of Medical Data Science, Graduate School of Medicine, Wakayama Medical University, Wakayama, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

TAROH SATOH

10Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Osaka, Japan;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Info & Metrics
PDF

Article Figures & Data

Figures

Tables

Download figure
Open in new tab
Download powerpoint
Figure 1.
Kaplan-Meier curve of progression-free survival (PFS) in elderly patients with colorectal cancer treated with first-line capecitabine plus bevacizumab (N=33). CI: Confidence interval.
Download figure
Open in new tab
Download powerpoint
Figure 2.
Kaplan-Meier curve of overall survival (OS) in elderly patients with colorectal cancer treated with first-line capecitabine plus bevacizumab (N=33). CI: Confidence interval.

Tables

Figures

PreviousNext

In this issue

In Vivo

Vol. 39, Issue 3

May-June 2025

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author
Back Matter (PDF)
Ed Board (PDF)
Front Matter (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on In Vivo.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Phase II Trial of Capecitabine Plus Bevacizumab for Elderly Patients With Metastatic Colorectal Cancer: OGSG 1102

Message Subject (Your Name) has sent you a message from In Vivo

Message Body (Your Name) thought you would like to see the In Vivo web site.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Math question * 7 + 7 =

Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.

Citation Tools

Phase II Trial of Capecitabine Plus Bevacizumab for Elderly Patients With Metastatic Colorectal Cancer: OGSG 1102

In Vivo May 2025, 39 (3) 1505-1513; DOI: 10.21873/invivo.13950

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Reprints and Permissions

Phase II Trial of Capecitabine Plus Bevacizumab for Elderly Patients With Metastatic Colorectal Cancer: OGSG 1102

In Vivo May 2025, 39 (3) 1505-1513; DOI: 10.21873/invivo.13950

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Jump to section

Article
Figures & Data
Info & Metrics
PDF

Cited By...

Polymorphisms of FGFR Pathway-related Factors and Capecitabine-induced Hand-foot Syndrome in Japanese Patients With Colorectal Cancer

Google Scholar

Keywords

colorectal cancer
elderly
capecitabine plus bevacizumab

Main menu

User menu

Search

Phase II Trial of Capecitabine Plus Bevacizumab for Elderly Patients With Metastatic Colorectal Cancer: OGSG 1102

Article Figures & Data

Figures

Tables

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Keywords